Teva Pharmaceutical Industries (TEVA)
Add to Watchlists Create an Alert
39.34
-0.15 -0.38%
NYSE
May 24, 8:00PM
BATS Real time
Currency in USD
Teva Pharmaceutical Industries Free Cash Flow:
838.00M for March 31, 2013Teva Pharmaceutical Industries Historical Free Cash Flow Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 838.00M |
| Dec. 31, 2012 | 1.25B |
| Sept. 30, 2012 | 799.00M |
| June 30, 2012 | 937.00M |
| March 31, 2012 | 482.00M |
| Dec. 31, 2011 | 1.111B |
| Sept. 30, 2011 | 206.00M |
| June 30, 2011 | 1.098B |
| March 31, 2011 | 666.00M |
| Dec. 31, 2010 | 868.00M |
| Sept. 30, 2010 | 1.019B |
| June 30, 2010 | 818.00M |
| March 31, 2010 | 721.00M |
| Dec. 31, 2009 | 745.00M |
| Sept. 30, 2009 | 829.00M |
| June 30, 2009 | 347.00M |
| March 31, 2009 | |
| Dec. 31, 2008 | 788.00M |
| Sept. 30, 2008 | 532.00M |
| June 30, 2008 | 626.00M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Free Cash Flow
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More
TEVA Free Cash Flow Benchmarks
| Companies | |
|---|---|
| Pfizer | 2.039B |
| Mylan | 34.49M |
| Alexza Pharmaceuticals | -9.426M |
TEVA Free Cash Flow Rankings
| Overall |
98th percentile 92 of 7600 |
| Sector |
97th percentile 17 of 653 in Healthcare |
| Industry |
98th percentile 1 of 66 in Drug Manufacturers - Specialty & Generic |
TEVA Free Cash Flow Range, Past 5 Years
| Minimum | 206.00M | Sep 2011 |
| Maximum | 1.25B | Dec 2012 |
| Average | 772.63M |
